๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection

โœ Scribed by O. M. Jones; M. Rees; T. G. John; S. Bygrave; G. Plant


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
94 KB
Volume
92
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Background

Liver resection is increasingly being performed for metastatic colorectal cancer. This study assessed the need for preoperative biopsy of suspected metastases and whether biopsy has any effect on long-term survival.

Methods

Prospectively collected data on patients who underwent liver resection for colorectal metastases between 1986 and 2003 were reviewed retrospectively. The endpoints of morbidity, operative mortality and long-term survival were compared between patients who had biopsy before referral (group 1) and those who did not (group 2).

Results

Patient demographics and disease distribution were similar for 90 patients in group 1 and 508 in group 2. Seventeen patients (19 per cent) who had undergone biopsy either at the time of colorectal resection or radiologically had evidence of needle-track deposits. Operative mortality and morbidity rates in the two groups were similar. The 4-year survival rate after liver resection was 32ยท5 (s.e. 5ยท5) per cent in group 1, compared with 46ยท7 (2ยท8) per cent in group 2 (P = 0ยท008).

Conclusion

Needle-track deposits are common after biopsy of suspected colorectal liver metastases. Biopsy of metastases confers poorer long-term survival on patients after liver resection and cannot be justified in patients with potentially resectable disease.


๐Ÿ“œ SIMILAR VOLUMES


Impact of bevacizumab on functional reco
โœ D. A. Wicherts; R. J. de Haas; M. Sebagh; E. Saenz Corrales; D. L. Gorden; F. Lรฉ ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 151 KB ๐Ÿ‘ 1 views

## Abstract ## Background The impact of bevacizumab on functional recovery and histology of the liver was evaluated in patients undergoing hepatic resection for colorectal liver metastases (CLM) following bevacizumab treatment. ## Methods Consecutive patients who had resection of CLM between Jul